| # | Drug | Count |
|---|---|---|
| 0 | RITONAVIR | 25 |
| 1 | LAMIVUDINE | 21 |
| 2 | LAMIVUDINE ORAL | 21 |
| 3 | RITONAVIR 100 MG | 21 |
| 4 | ERGOTAMINE TARTRATE | 11 |
| 5 | LOPINAVIR AND RITONAVIR | 10 |
| 6 | ZIDOVUDINE | 10 |
| 7 | ERGOTAMINE TARTRATE AND CAFFEINE | 9 |
| 8 | ATAZANAVIR | 8 |
| 9 | ERYTHROMYCIN | 7 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ERGOTAMINE TARTRATE AND CAFFEINE | 9 | 0.0333 |
| 1 | METHYLERGONOVINE MALEATE | 6 | 0.0098 |
| 2 | DIHYDROERGOTAMINE MESYLATE | 4 | 0.0030 |
| 3 | SODIUM NITROPRUSSIDE | 1 | 0.0026 |
| 4 | SODIUM THIOSULFATE | 1 | 0.0018 |
| 5 | RITONAVIR 100 MG | 21 | 0.0014 |
| 6 | ZIDOVUDINE | 10 | 0.0010 |
| 7 | LAMIVUDINE | 21 | 0.0008 |
| 8 | LOPINAVIR AND RITONAVIR | 10 | 0.0007 |
| 9 | PSYLLIUM HUSK | 1 | 0.0007 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Protease Inhibitor [EPC] | 35 | 0.0008 |
| 1 | Oxytocic [EPC] | 2 | 0.0007 |
| 2 | Cytochrome P450 3A Inhibitor [EPC] | 37 | 0.0006 |
| 3 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 22 | 0.0004 |
| 4 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 28 | 0.0003 |
| 5 | Macrolide Antimicrobial [EPC] | 11 | 0.0002 |
| 6 | Methylxanthine [EPC] | 9 | 0.0002 |
| 7 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 3 | 0.0001 |
| 8 | Vitamin K [EPC] | 1 | 0.0001 |
| 9 | Central Nervous System Stimulant [EPC] | 9 | 0.0001 |